Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination
- PMID: 604107
Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination
Abstract
Serum HI and neuraminidase-inhibiting (NI) antibody measurements were made at 3, 32 and 50 weeks after inactivated influenza Hsw1N1 vaccination of 438 adults in 1976. Although the highest postvaccination geometric mean HI titers were observed in persons greater than or equal to 52 years of age, the rate of antibody decline was similar in adults of all ages. In 14 children who had a seroconversion following two doses of whole virus or split virus vaccine, the geometric mean HI antibody titer was lower after the second vaccine dose than the peak titer observed in adults, and the decrease in titer was also more rapid by 4 to 7 months. One year after influenza Hsw1N1 vaccination of adults, the prevalence of homologous HI antibody greater than or equal to 40 was 71% to 97%, whereas only two of the 14 children maintained similar titers at 5 to 7 months. Neuraminidase-inhibiting antibody titer formation occurred more frequently in those without prevaccination NI antibody, but the rate of decline was also greatest in this initially seronegative group. The rate of antibody decline at one year in the population with preexisting antibody was similar to that observed for HI antibody decline in a primed population. Heterologous influenza A/Victoria/3/75 (H3N2) HI antibody formation occurred in 22% of adults aged 25 to 51 after Hsw1N1 vaccination and in 12% of those over the age of 51, but the rate of heterologous antibody decline was more rapid than that observed for homologous antibody.
Similar articles
-
Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine.Can Med Assoc J. 1979 Apr 7;120(7):799-802, 831. Can Med Assoc J. 1979. PMID: 427686 Free PMC article.
-
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?Pediatrics. 2006 Sep;118(3):e570-8. doi: 10.1542/peds.2006-0198. Pediatrics. 2006. PMID: 16950948 Clinical Trial.
-
HI antibody response in volunteers vaccinated with live influenza A/New Jersey/76 vaccine.Dev Biol Stand. 1977 Jun 1-3;39:67-71. Dev Biol Stand. 1977. PMID: 342319 Clinical Trial.
-
Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.J Med Virol. 2007 Mar;79(3):320-5. doi: 10.1002/jmv.20801. J Med Virol. 2007. PMID: 17245715
-
[Host and exacerbation factors related to influenza susceptibility].Nihon Rinsho. 2003 Nov;61(11):1921-5. Nihon Rinsho. 2003. PMID: 14619432 Review. Japanese.
Cited by
-
Studies with inactivated equine influenza vaccine. 1. Serological responses of ponies to graded doses of vaccine.J Hyg (Lond). 1983 Jun;90(3):371-84. doi: 10.1017/s0022172400029004. J Hyg (Lond). 1983. PMID: 6345659 Free PMC article.
-
Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.J Clin Microbiol. 1989 Dec;27(12):2666-71. doi: 10.1128/jcm.27.12.2666-2671.1989. J Clin Microbiol. 1989. PMID: 2592535 Free PMC article.
-
Influence of prior influenza vaccination on antibody and B-cell responses.PLoS One. 2008 Aug 20;3(8):e2975. doi: 10.1371/journal.pone.0002975. PLoS One. 2008. PMID: 18714352 Free PMC article.
-
Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.Vaccine. 2011 Apr 12;29(17):3183-91. doi: 10.1016/j.vaccine.2011.02.040. Epub 2011 Mar 1. Vaccine. 2011. PMID: 21371580 Free PMC article.
-
Vaccination against virus diseases.Soz Praventivmed. 1979 Oct;24(5):335-45. doi: 10.1007/BF02083602. Soz Praventivmed. 1979. PMID: 394510 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical